Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$823M |
| 2 |
Apple
AAPL
|
+$796M |
| 3 |
Amazon
AMZN
|
+$437M |
| 4 |
NVIDIA
NVDA
|
+$408M |
| 5 |
Kenvue
KVUE
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$434M |
| 2 |
Johnson & Johnson
JNJ
|
+$135M |
| 3 |
LSI
Life Storage, Inc.
LSI
|
+$128M |
| 4 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$75.9M |
| 5 |
WWE
World Wrestling Entertainment
WWE
|
+$68.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.81% |
| 2 | Healthcare | 12.27% |
| 3 | Financials | 11.08% |
| 4 | Consumer Discretionary | 9.71% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4001
Pyxis Oncology
PYXS
$193M
| $105K | ﹤0.01% |
52,746
+5,353
| +11% | +$12.4K |
|
4002
Personalis
PSNL
$1.5B
| $105K | ﹤0.01% |
86,591
-2,886
| -3% | -$5.16K |
|
4003
Arena Group
AREN
$70M
| $105K | ﹤0.01% |
24,418
| – | – |
|
|
SYRS
4004
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $104K | ﹤0.01% |
26,394
+5,667
| +27% | +$21.2K |
|
4005
Flotek Industries
FTK
$1.4B
| $104K | ﹤0.01% |
23,418
+4,086
| +21% | +$19.4K |
|
4006
Shattuck Labs
STTK
$767M
| $103K | ﹤0.01% |
68,066
-2,152
| -3% | -$4.91K |
|
|
IRD
4007
Opus Genetics
IRD
$328M
| $103K | ﹤0.01% |
30,870
-297
| -1% | -$1.19K |
|
4008
United States Natural Gas Fund
UNG
$505M
| $102K | ﹤0.01% |
3,750
| – | – |
|
|
PRPH
4009
DELISTED
ProPhase Labs
PRPH
| $102K | ﹤0.01% |
2,342
-20
| -0.8% | -$1.17K |
|
4010
Heartbeam
BEAT
$32.3M
| $102K | ﹤0.01% |
47,325
| – | – |
|
4011
Broadwind
BWEN
$123M
| $102K | ﹤0.01% |
31,730
-287
| -0.9% | -$1.09K |
|
4012
Great Elm Group
GEG
$67.4M
| $101K | ﹤0.01% |
47,112
| – | – |
|
4013
Aquestive Therapeutics
AQST
$531M
| $100K | ﹤0.01% |
65,500
| – | – |
|
4014
Comscore
SCOR
$108M
| $99.9K | ﹤0.01% |
8,138
-871
| -10% | -$12.3K |
|
4015
Cardiff Oncology
CRDF
$80.1M
| $99.2K | ﹤0.01% |
71,386
-1,000
| -1% | -$1.69K |
|
4016
IRIDEX
IRIX
$14.8M
| $99.1K | ﹤0.01% |
39,013
-684
| -2% | -$1.3K |
|
|
PPIH
4017
Perma-Pipe International
PPIH
$216M
| $98.3K | ﹤0.01% |
12,038
-2,006
| -14% | -$17.2K |
|
4018
CEL-SCI Corp
CVM
$25.7M
| $97.8K | ﹤0.01% |
2,608
| – | – |
|
4019
Ideal Power
IPWR
$70.8M
| $97.3K | ﹤0.01% |
10,038
-93
| -0.9% | -$1.03K |
|
|
TUP
4020
DELISTED
Tupperware Brands Corporation
TUP
| $97.2K | ﹤0.01% |
69,442
-5,467
| -7% | -$12.3K |
|
|
CYT
4021
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $97.1K | ﹤0.01% |
34,189
+15,205
| +80% | +$41.9K |
|
4022
Annovis Bio
ANVS
$80M
| $96.6K | ﹤0.01% |
10,180
| – | – |
|
4023
Assembly Biosciences
ASMB
$535M
| $95.7K | ﹤0.01% |
9,010
| – | – |
|
|
DMTK
4024
DELISTED
DermTech, Inc. Common Stock
DMTK
| $95.2K | ﹤0.01% |
66,100
-64
| -0.1% | -$160 |
|
4025
Corvus Pharmaceuticals
CRVS
$1.27B
| $94.9K | ﹤0.01% |
65,017
| – | – |
|
Similar funds
Northern Trust's Q3 2023 Portfolio in Review
As of Q3 2023, Northern Trust held 4,620 positions worth $516B, down 0.79% from $520B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Northern Trust's Q3 2023 filing shows 87 new, 2,316 increased, 1,712 reduced and 155 closed positions. Its largest new stake was TKO Group: 634,416 shares worth $53.3M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $434M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- Northern Trust's largest Q3 2023 buy was TKO Group: 634,416 shares worth $53.3M.
- Northern Trust added most to Microsoft in Q3 2023, an estimated $823M increase.
- Northern Trust's biggest Q3 2023 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $434M.
- Northern Trust fully exited Life Storage, Inc. in Q3 2023, selling an estimated $128M.
- Northern Trust's ten largest holdings make up 23% of its $516B portfolio in Q3 2023.
- Northern Trust opened 87 new positions and closed 155 in Q3 2023.
- Northern Trust's portfolio value fell 0.79% quarter-over-quarter to $516B.
Based on Northern Trust's 13F filing for Q3 2023, filed 13 Nov 2023.